FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    747350014 Two (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clioquinol 10 milligram/1 milliliter and flumetasone pivalate 200 microgram/1 milliliter conventional release ear drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine hydrochloride 10 milligram/1 gram and nystatin 100000 unit/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Busulfan 2mg tablets (A A H Pharmaceuticals Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Busulfan 2mg tablets (A A H Pharmaceuticals Ltd) 25 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Biperiden 2mg tablets (Special Order) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Nitisinone 2mg capsules (WEP Clinical) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Biperiden 2mg tablets 1 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Biperiden 2mg tablets (Special Order) 1 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Nitisinone 2mg capsules (WEP Clinical) 60 capsule Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Lacidipine 2mg tablets (Zentiva Pharma UK Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Lacidipine 2mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Candesartan 2mg tablets (Milpharm Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Doxazosin 2mg tablets (Milpharm Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Candesartan 2mg tablets (Milpharm Ltd) 7 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Doxazosin 2mg tablets (Milpharm Ltd) 28 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Risperidone 2mg tablets (Milpharm Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Risperidone 2mg tablets (Milpharm Ltd) 60 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Telmisartan 80mg / Hydrochlorothiazide 12.5mg tablets (Accord Healthcare Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Telmisartan 80mg / Hydrochlorothiazide 12.5mg tablets (Accord Healthcare Ltd) 28 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Loperamide 2mg capsules (Wockhardt UK Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Loperamide 2mg capsules (Wockhardt UK Ltd) 30 capsule Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 100mg / Hydrochlorothiazide 25mg tablets (Medreich Plc) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops (Medicom Healthcare Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Brimonidine 2mg/ml eye drops (Medicom Healthcare Ltd) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Medox 50micrograms/ml / 5mg/ml eye drops (Medicom Healthcare Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 100mg / Hydrochlorothiazide 25mg tablets (Medreich Plc) 28 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops (Medicom Healthcare Ltd) 5 ml Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Brimonidine 2mg/ml eye drops (Medicom Healthcare Ltd) 5 ml Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Medox 50micrograms/ml / 5mg/ml eye drops (Medicom Healthcare Ltd) 2.5 ml Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg tablets (Consilient Health Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/125mg tablets (Consilient Health Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Dicycloverine 10mg/5ml oral solution (Morningside Healthcare Ltd) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Doxazosin 2mg tablets (Ennogen Pharma Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Crescent Pharma Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 250mg/125mg tablets (Consilient Health Ltd) 21 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/125mg tablets (Consilient Health Ltd) 21 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Dicycloverine 10mg/5ml oral solution (Morningside Healthcare Ltd) 120 ml Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Doxazosin 2mg tablets (Ennogen Pharma Ltd) 28 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Pioglitazone 15mg / Metformin 850mg tablets (Alliance Healthcare (Distribution) Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Pioglitazone 15mg / Metformin 850mg tablets (Alliance Healthcare (Distribution) Ltd) 56 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 100mg / Hydrochlorothiazide 25mg tablets (Xiromed) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Xiromed) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 100mg / Hydrochlorothiazide 25mg tablets (Xiromed) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Xiromed) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Tetris Pharma Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 2g powder for solution for infusion vials (Tetris Pharma Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Ceftazidime 2g powder for solution for injection vials (Tetris Pharma Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Ceftriaxone 2g powder for solution for infusion vials (Tetris Pharma Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Ethinylestradiol 20microgram / Gestodene 75microgram tablets 21 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ethinylestradiol 30microgram / Gestodene 75microgram tablets 21 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) 100 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Fresenius Kabi Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/100mg powder for solution for injection vials (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Fresenius Kabi Ltd) 1 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/100mg powder for solution for injection vials (Sandoz Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd) 21 tablet 3 x 7 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftriaxone 2g powder for solution for injection vials (Stragen UK Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Fycompa 2mg tablets (Originalis B.V.) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Valsartan 80mg / Hydrochlorothiazide 12.5mg tablets (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Sandoz Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Kivexa 600mg/300mg tablets (Originalis B.V.) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Ceftriaxone 2g powder for solution for injection vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Sandoz Ltd) 10 vial Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Fycompa 2mg tablets (Originalis B.V.) 7 tablet Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Valsartan 80mg / Hydrochlorothiazide 12.5mg tablets (Sandoz Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Valsartan 160mg / Hydrochlorothiazide 25mg tablets (Sandoz Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets (Sandoz Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Kivexa 600mg/300mg tablets (Originalis B.V.) 30 tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Risperidone 2mg tablets (Torrent Pharma (UK) Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Pioglitazone 15mg / Metformin 850mg tablets (Torrent Pharma (UK) Ltd) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Tolterodine 2mg tablets (Torrent Pharma (UK) Ltd) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1

    Start Previous Page 34 of 35 End

    This concept is not in any reference sets

    Back to Start